FDA’s curb on overseas cell processing to hit smaller cell and gene therapy companies: GlobalData Read more
Trump’s move to transform US pharma manufacturing raises doubts over its effectiveness: GlobalData Read more
Granules India’s Gagillapur facility classified as “Official Action Indicated” following US FDA Inspection Read more